Start-Up Quarterly Statistics: Fundraising Fell, But Deal-Making Rose In Q3
Executive Summary
A review of biopharma start-up deal-making and financing activity from July through September 2017, based on data from Strategic Transactions, showed that fundraising declined 18% from the previous quarter, however the number of acquisitions doubled to eight.